Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF plus Reduced Dose Antimony for Cutaneous Leishmaniasis
NCT00973128Phase 2Completed
- Sponsor
- Hospital Universitário Professor Edgard Santos
- Start
- Feb 2004
- Primary completion
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in cutaneous leishmaniasis (CL), sponsored by Hospital Universitário Professor Edgard Santos. Started Feb 2004; status: completed.
02
Drugs
sargramostim
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00973128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00973128.